Skip to main content
. 2018 Jan 14;24(2):248–256. doi: 10.3748/wjg.v24.i2.248

Table 3.

Allele and genotype frequencies of IRF5 rs77416878C/T and rs2280714T/C in Vietnamese patients with hepatitis B virus-related liver diseases n (%)

IRF5 variants HC, n = 242 CHB, n = 99 LC, n = 131 HCC, n = 149
rs77416878
CC 192 (79.4) 79 (79.8) 98 (74.8) 115 (77.2)
CT 48 (19.8) 19 (19.2) 32 (24.4) 31 (20.8)
TT 2 (0.8) 1 (1) 1 (0.8) 3 (2)
Allele
C 432 (89.3) 177 (89.4) 228 (87) 261 (87.6)
T 52 (10.7) 21 (10.6) 34 (13) 37 (12.4)
Dominant
CC 192 (79.4) 79 (79.8) 98 (74.8) 115 (77.2)
CT + TT 50 (20.6) 20 (20.2) 33 (24.4) 34 (22.8)
Recessive
CC + CT 240 (99.2) 98 (99) 130 (99.2) 146 (98)
TT 2 (0.8) 1 (1) 1 (0.8) 3 (2)
rs2280714
TT 84 (34.7) 31 (31.3) 47 (35.9) 39 (26.2)
TC 114 (47.1) 52 (52.5) 69 (52.7) 87 (58.4)
CC 44 (18.2) 16 (16.2) 15 (11.4) 23 (15.4)
Allele
T 282 (58.3) 114 (57.6) 163 (62.2) 165 (55.4)
C 202 (41.7) 84 (42.4) 99 (37.8) 133 (44.6)
Dominant
TT 84 (34.7) 31 (31.3) 47 (35.9) 39 (26.2)
TC + TT 158 (65.3) 78 (68.7) 84 (64.1) 110 (73.8)
Recessive
TT + TC 198 (81.8) 83 (83.8) 116 (88.6) 126 (84.6)
CC 44 (18.2) 16 (16.2) 15 (11.4) 23 (15.4)

HC: Healthy controls; CHB: Chronic hepatitis B; LC: Liver cirrhosis; HCC: Hepatocellular carcinoma. All comparisons between groups using binary logistic model adjusted for age and gen did not indicate a significant difference (adjusted P > 0.05, data not shown in this table).